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Abstract
M. tuberculosis N-acetyl-glucosamine-1-phosphate uridyltransferase (GlmUMtb) is a bi-
functional enzyme engaged in the synthesis of two metabolic intermediates N-acetylgluco-
samine-1-phosphate (GlcNAc-1-P) and UDP-GlcNAc, catalyzed by the C- and N-terminal
domains respectively. UDP-GlcNAc is a key metabolite essential for the synthesis of pepti-
doglycan, disaccharide linker, arabinogalactan and mycothiols. While glmUMtb was pre-
dicted to be an essential gene, till date the role of GlmUMtb in modulating the in vitro growth
ofMtb or its role in survival of pathogen ex vivo / in vivo have not been deciphered. Here we
present the results of a comprehensive study dissecting the role of GlmUMtb in arbitrating
the survival of the pathogen both in vitro and in vivo. We find that absence of GlmUMtb leads
to extensive perturbation of bacterial morphology and substantial reduction in cell wall thick-
ness under normoxic as well as hypoxic conditions. Complementation studies show that the
acetyl- and uridyl- transferase activities of GlmUMtb are independently essential for bacterial
survival in vitro, and GlmUMtb is also found to be essential for mycobacterial survival in
THP-1 cells as well as in guinea pigs. Depletion of GlmUMtb from infected murine lungs, four
weeks post infection, led to significant reduction in the bacillary load. The administration of
Oxa33, a novel oxazolidine derivative that specifically inhibits GlmUMtb, to infected mice
resulted in significant decrease in the bacillary load. Thus our study establishes GlmUMtb as
a strong candidate for intervention measures against established tuberculosis infections.
Author Summary
The synthesis of theMtb cell wall involves a cascade of reactions catalyzed by cytosolic
and cell membrane-bound enzymes. The reaction catalyzed by GlmUMtb (an enzyme with
acetyltransferase and uridyltransferase activities) generates UDP-GlcNAc, a central nucle-
otide-sugar building block of the cell wall. Apart from cell wall synthesis UDP-GlcNAc is
an essential metabolite participating in other cellular processes including disaccharide
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linker and mycothiol biosynthesis. GlmUMtb shares very little sequence similarity with
eukaryotic acetyltransferase and uridyltransferase enzymes. Many pathogens have alterna-
tive pathway(s) for foraging GlcNAc from the host. The present study was undertaken to
see the effects of depleting GlmUMtb on pathogen survival in the host animal. We have
generated a conditional gene replacement mutant of glmUMtb and find that depletion of
GlmUMtb at any stage of bacterial growth or in mice infected withMtb including a well-
established infection, results in irreversible bacterial death due to perturbation of cell wall
synthesis. We have developed a novel anti-GlmUMtb inhibitor (Oxa33), identified its bind-
ing site on GlmUMtb, and shown its specificity for GlmUMtb. The study demonstrates that
GlmUMtb is a promising target for therapeutic intervention and Oxa33 can be pursued as a
lead molecule.
Introduction
The cell wall, which contains a number of virulence determinants, is the first line of defence for
survival of the pathogen in the hostile host environment [1]. The mycobacterial cell envelope
includes three layers of cell membrane and a cell wall made up of peptidoglycan, mycolic acid,
arabinogalactan and lipoarabinomannan (LAM) [2–4]. Most existing first line and second line
drugs used to treat TB such as isoniazid, ethambutol, ethionamide and cycloserine, act on
enzymes engaged in the synthesis of different cell wall components [5]. The current high mor-
tality rates of infected individuals as well as increasing incidence of multidrug-resistant (MDR)
and extensively drug-resistant (XDR) tuberculosis (TB) among patients underscore the impor-
tance of finding new targets for therapeutic intervention.
GlmUMtb is a bi-functional enzyme, with acetyltransferase and uridyltransferase activities
catalyzed by the C- and N- terminal domains respectively (Fig 1A) [6,7]. The carboxy-terminal
domain of GlmUMtb transfers the acetyl moiety from acetyl CoA onto glucosamine-1-phos-
phate to generate N-acetylglucosamine-1-phosphate (GlcNAc-1-P). The N-terminal uridyl-
transferase domain of GlmUMtb then catalyzes the transfer of UMP (from UTP) to GlcNAc-
1-P to form UDP-GlcNAc (Fig 1A) [6]. The UDP-GlcNAc thus produced is among the central
metabolites that is required for the synthesis of peptidoglycan, lipid A of LAM, arabinogalac-
tan, Rha-GlcNAc linkers, mycothiol (required for maintaining redox homeostasis) [8–14]. The
crystal structure ofM. tuberculosis GlmU (GlmUMtb) displays two-domain architecture with
an N-terminal α/β- like fold and a C-terminal left-handed parallel-β-helix structure [15,16].
Unlike its orthologs, GlmUMtb has a long carboxy-terminal tail which displays little secondary
structure [17]. Results from transposon mutagenesis experiments have indicated glmUMtb to be
an essential gene, supported by the fact thatM. smegmatis is unable to grow in the absence of
glmUsmeg [18–20]. However, no studies have addressed the question of whether both the activi-
ties of GlmUMtb are independently essential for the growth or survival of the bacterium.
While the enzymes required for the synthesis of UDP-GlcNAc are well conserved among
prokaryotes, they are very different from those found in eukaryotes, making GlmUMtb an
attractive putative drug target [21,22]. Researchers have developed compounds that inhibit the
activities of the orthologs of GlmUMtb (GlmU from T. brucei, P. aeruginosa, E. coli,H. influenza
and X. oryzae) in vitro [23–30]. Bioinformatic analyses and kinetic modelling data advocate
GlmUMtb to be a potential target for the development of suitable inhibitors [31]. In concur-
rence with these predictions, effective inhibitors have been developed against, the acetyltrans-
ferase and uridyltransferase domains of GlmUMtb [32,33]. However, the precise sites of
inhibitor-protein interactions and the efficacy of the inhibitors ex vivo or in vivo have not been
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Fig 1. Generation of glmUMtb conditional deletionmutant. (A) Schematic depicting the biochemical
reaction catalyzed by GlmUMtb. (B) Schematic diagram representing the genomic location of glmUMtb
(Rv1018c) and homologous recombination between flanking sequence in the phagemid and the genomic
locus. Primers used for the PCR amplification are depicted. Upper right panel shows the immunoblot. WCLs
from Rv or Rv::glmU grown in the presence or absence of ATc were resolved and probed with anti-GlmU
antibodies. Bands corresponding to the endogenous GlmU and ectopic FLAG-GlmU are indicated. (C)
Agarose gel showing the PCR amplification of the Rv & putative RvΔglmUmutant using specific primers.
Primers F1 and R2 are beyond the flanks, R1 and F2 belong to resolvase sites in sacB/hygR cassette and F3
and R3 binds to the native glmU. Amplification with F1-R1 or F2-R2 primers results in 1.23 kb or 1.17 kb size
products with RvΔglmU strain but none with the Rv. Whereas PCRs with F1-R3 or F3-R2 primers amplifies
1.5 kb band with the Rv and none with the RvΔglmUmutant. (D)Whole cell lysates (WCL) were prepared
from the large scale cultures of Rv and RvΔglmU grown in the absence and presence of ATc for five days.
20 μg of WCLs were resolved and probed with anti-GlmUMtb, anti-PknB and anti-GroEL1 antibodies. Band
corresponding to endogenous GlmUMtb and FLAG-GlmUMtb are indicated.
doi:10.1371/journal.ppat.1005235.g001
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investigated. SubjectingMtb cultures in vitro to gradual decrease of oxygen (hypoxic stress)
results in reprogramming of metabolic pathways and up-regulation of stress response genes,
and is considered to be an in vitromodel for the dormancy [34,35]. The importance of
GlmUMtb for growth under hypoxic conditions and in an in vivo infection model is yet to be
investigated. In the present study we have generated a conditional gene replacement mutant of
glmUMtb and used this mutant to investigate any role GlmUMtb may play in modulating the
growth of the bacterium in vitro, ex vivo and in vivo. The data presented here demonstrate that
GlmUMtb is a viable and promising target for therapeutic intervention against tuberculosis.
Results
GlmUMtb depletion perturbs cell wall structure and affects the bacterial
survival in normoxia
As the tetracycline-inducible system is an effective means to regulate gene expression [36], we
introduced the integration-proficient pST-KirT-glmU construct (wherein glmUMtb gene was
cloned under a promoter that shuts down upon ATc addition; S1A Fig) intoMtb H37Rv (Fig
1B). Whereas the expression of GlmUMtb from its native locus remained unaltered, the expres-
sion of FLAG-GlmUMtb in Rv::glmU strain was drastically compromised in the presence of
ATc (Western blot inset, Fig 1B). This merodiploid strain was transduced with temperature
sensitive phage, and the fidelity of homologous recombination at the native locus was con-
firmed by amplification across the replacement junctions using appropriate primers (Fig 1C).
A comparison of GlmUMtb expression in the presence and absence of ATc revealed that the
protein was not detectable by western blot analysis after 6 days of growth in the presence of
ATc (Fig 1D). While the growth of RvΔglmU in the absence of ATc was similar to Rv, in the
presence of ATc the growth was drastically compromised (Fig 2A). A comparative analysis of
growth by spotting of serially diluted cultures of Rv and RvΔglmU grown in the presence versus
absence of ATc showed that GlmUMtb depletion by addition of ATc led to complete inhibition
of growth, with no growth detected after 6 days (Fig 2B). Interestingly, analysis of GlmUMtb
expression every 24 hours post-ATc addition uncovered significant reduction in GlmUMtb
expression by the third day itself (Fig 2C). These results indicate that GlmUMtb is required for
theMtb survival. To determine the impact of GlmUMtb depletion on cellular morphology we
carried out SEM and TEM imaging analysis of Rv and RvΔglmU cells grown for three days in
the absence or presence of ATc. SEM analysis revealed severe morphological perturbations in
the absence of GlmUMtb, with the bacilli showing wrinkled surface and fused cells (Fig 2D).
TEM analysis showed that whereas in Rv and RvΔglmU cell wall structure and thickness are
comparable, there was a marked decrease in cell wall thickness in RvΔglmU cells where
GlmUMtb was not expressed (cells grown in the presence of ATc; Fig 2E and 2F).
Impact of GlmUMtb depletion on dormant bacteria
Next we used the Wayne model to investigate the consequence of GlmUMtb depletion on the
dormant bacteria under hypoxic conditions [35]. Accordingly, hypoxia was established and
maintained for 42 days with depletion of GlmUMtb or addition of INH for either 22 days, or for
2 days (Fig 3A, line diagram). In agreement with previous reports, we observed that bacteria
were tolerant to INH under hypoxic conditions [37] (Fig 3C), with a thicker cell wall being
observed under hypoxic conditions compared with the normoxic cultures (Fig 3D and 3E).
Depletion of GlmUMtb for 22 days resulted in complete clearance of growth (Fig 3B), which
was also reflected in severe morphological perturbations and drastic reduction in cell wall
thickness (Fig 3D and 3E). Significantly, GlmUMtb depletion for as less as 2 days decreased cell
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Fig 2. GlmUMtb depletion affects the bacterial survival by perturbing the cell wall structure. (A) Rv and
RvΔglmU cultures grown to an A600 of 0.8 were used to seed fresh cultures at an initial A600 of 0.1 in the
presence or absence of ATc as indicated and the day wise growth was monitored for six days. Inset shows
the growth in the culture tubes after six days. The experiment was performed in triplicates (n = 3). Error bars
indicate standard error of mean (s.e.m). (B) Day 0 and Day 6 cultures grown in the presence or absence of
ATc were serially diluted and spotted on 7H11 agar plates. (C) Large scale cultures were inoculated at A600 of
0.1 in the presence or absence of ATc and theWCLs were prepared on different days post ATc addition (as
indicated). WCLs were resolved and probed with anti-GlmUMtb and anti-GroEL1 antibodies. (D) Scanning
electron microscopy of Rv and RvΔglmU grown for 72 h with or without ATc as indicated. Scale bars in upper
panel were 10 nm and for the inset was 200 nm. The experiment was repeated thrice. (E) Transmission
electron micrographs results at 50,000X of Rv and RvΔglmU cultures grown with or without ATc. Red lines
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viability by three orders of magnitude (Fig 3B) and decrease in cell wall thickness (~18%; Fig
3D and 3E). Taken together, the data suggests that the absence of GlmUMtb in hypoxic condi-
tion leads to aberrant cell wall thickness and morphology, eventually leading to the death of the
cell.
Acetyl and uridyltransferase activities of GlmUMtb are independently
essential
Biochemical investigations have shown that the N-terminal fragment (1–352 amino acids) and
C-terminal fragment (150–495 amino acids) of GlmUMtb can independently undertake uridyl-
transferase and acetyltransferase activities respectively (Fig 4A and 4B) [15,17]. The active site
residues that are necessary for these activities have also been identified (Fig 4A and 4B) [17].
To investigate if both activities are essential for cell survival, we have generated previously
reported truncation mutants GlmU-N and GlmU-C [38]. We also generated GlmUK26A and
GlmUH374A, the uridyltransferase and acetyltransferase active site mutants, and GlmUDM
wherein both the active site residues were concomitantly mutated. GlmUMtb wild type and
mutant proteins were purified (Fig 4C) and their uridyltransferase and acetyltransferase activi-
ties were assayed. While GlmU-C and GlmUK26A mutants showed acetyltransferase activity, as
expected they did not show any uridyltransferase activity (Fig 4D). On the other hand
GlmU-N and GlmUH374A had uridyltransferase activity but not the acetyltransferase activity
(Fig 4D). As expected the double mutant did not have either uridyl or acetyltransferase activity
(Fig 4D). Next complementation assays using one or other truncations / active site mutants
were carried out. The FLAG-GlmUMtb and the complemented untagged wt-GlmUMtb proteins
were found to be expressed at similar levels (Fig 4E). The episomally expressed wt-GlmUMtb
could rescue the RvΔglmU phenotype in the presence of ATc (Fig 4F). Contrastingly, while the
various GlmUMtb mutant proteins were expressed at levels comparable to that of FLAG-Gl-
mUMtb (Fig 4E); none of them rescued the growth defects of the RvΔglmU strain in the pres-
ence of ATc (Fig 4F). These results indicate that both uridyltransferase and acetyltransferase
activities of GlmUMtb are essential for pathogen survival and imply that the only source of the
metabolites GlcNAc-1-P and UDP-GlcNAc is through the GlmUMtb mediated synthesis
pathway.
Presence of GlmUMtb is obligatory for the survival ofMtb in the host
Mtb cells devoid of an intact cell wall have been found to be capable of surviving inside the host
[39,40]. Some pathogens have been reported to resort to cell wall “recycling” for the synthesis
of UDP-GlcNAc, and others have been known to utilize GlcNAc from the host for this purpose
[41–44]. However, such mechanisms have not yet been reported inMtb. To investigate these
possibilities we examined the impact of GlmUMtb depletion on survival of the pathogen in the
host. Using an ex vivo THP-1 infection model we observed ~80% phagolysosome fusion in the
absence of GlmUMtb (Fig 5A and 5B; compare RvΔglmU with RvΔglmU +ATc). This was also
reflected in the survival pattern of the pathogen upon depletion of GlmUMtb (Fig 5C), with sur-
vival being strongly compromised in absence of GlmUMtb. The impact of GlmUMtb depletion
was evident as early as 24 h post-infection, with a dramatic drop in survival by 48 hours post-
infection (Fig 5C). The consequences of GlmUMtb depletion on survival of the pathogen in vivo
were evaluated using guinea pig infection model. CFUs obtained 24 h after infection suggested
depict the cell wall thickness. Scale bar: 20 nm. (F) Cell wall thickness was measured in nm for 15 to 22 cells
for each sample. ***p<0.0001, two tailed non parametric t-test, mean, s.e.m.
doi:10.1371/journal.ppat.1005235.g002
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Fig 3. Effect of GlmUMtb depletion of dormant bacteria. (A) Schematic outline of the experiment. (B) Rv
and RvΔglmU cultures were seeded at an initial A600 of 0.1 in 1.5 HPLC tubes or in 500 ml flasks containing
penetrable caps. Establishment of hypoxia was monitored with the help of methylene blue color change (blue
to colorless). ATc was added to Rv on 20th day and to RvΔglmU on 20th and 40th day. CFUs were
enumerated on day 0, day 20 and day 42. *p<0.05 or ***p<0.005, two tailed non parametric t-test, Error bars
indicate s.e.m. and the experiment was performed in triplicates (n = 3). (C) INH (50 ng/ml) was added to the
hypoxic Rv cultures on 20th and 40th day. CFUs were enumerated on day 42. *p<0.05 or NS: non- significant,
two tailed non parametric t-test, Error bars indicate s.e.m. and n = 3. (D) Large scale hypoxic cultures were
pelleted down on day 42 and processed for scanning electron microscopy (upper panel) or transmission
electron microscopy (lower panel) imaging. (SEM: scale bars: 1 μm; TEM scale bar: 20 nm). Cell wall
thickness is indicated by red lines. (E)Cell wall thickness was measured in nm for 20 to 54 cells from the TEM
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images of different samples (representative image shown in Fig 3C). ***p< 0.0001 and 0.0005, two tailed
non parametric t-test, Error bars indicate s.e.m.
doi:10.1371/journal.ppat.1005235.g003
Fig 4. Acetyl and uridyltransferase activities are independently essential. (A) and (B) Schematic and cartoon representation of GlmUMtb depicting
different domains, active site residues and the deletion mutants. (C)GlmUMtb and GlmUMtb-mutants were purified as described earlier [38] and the 1 μg of the
purified proteins were resolved on 10% SDS-PAGE and stained with coomassie. (D) Uridyltransferase (left panel) and acetyltransferase (right panel)
activities were carried out as describe in Methods using 0.5 to 20 pmoles of wild type or mutant GlmUMtb proteins. Activity was defined as μM product formed /
min / pmole of enzyme. Relative activities of the mutants were calculated with respect to the activity of GlmUMtb, which was normalized to 100%. The
experiment was repeated three times and the error bars indicate s.e.m. (E)Wild type and mutated GlmUMtb genes were cloned into pNit vector without any N-
or C- terminal tag. pNit-glmUwt or pNit-glmUmutant constructs were electroporated into RvΔglmU, and theWCLs prepared from RvΔglmU and RvΔglmU::
glmUmutant cultures were resolved and probed with anti-GlmU and anti-GroEL1 antibodies. Bands corresponding to FLAG-GlmUMtb, complemented GlmUwt/
mutant and the deletion fragments of GlmU are indicated. (F) RvΔglmU and RvΔglmU::glmUmutant cultures were seeded at an initial A600 of 0.1 and grown for
five days in the absence or presence of ATc. The experiment was performed in triplicates and the error bars represent s.e.m.
doi:10.1371/journal.ppat.1005235.g004
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Fig 5. Presence of GlmUMtb is obligatory for the survival ofMtb in the host. (A) Confocal microscopy images of THP1 cells infected with Rv and
RvΔglmU in the presence or absence of ATc as indicated were taken 48 h post infection. Bacteria were stained with FITC (green) and lysosomes were
stained with Lyso Tracker red DND 99 (red). Scale bars, 10 μm. (B)Quantification of percentage co-localization of bacterium and lysosomes in Fig 3A. n = 10
to 15. (C) PMA differentiated THP1 cells were infected with Rv and RvΔglmU and either ATc (400 ng/ml) or the vehicle were added at 0 h. CFUs were
enumerated at different time points post infection. The experiment was performed in triplicates and error bars represent s.e.m. (D)Guinea pigs were infected
with 150–200 bacilli CFUs of Rv or RvΔglmU and Dox was provided in the water as indicated. Guinea pigs (n = 2) were sacrificed on day 1 and homogenates
from the lungs were plated in triplicates to determine the implantation. Guinea pigs (6 guinea pigs /group) were sacrificed four weeks post infection and CFUs
were determined in the lung homogenates and results were plotted with log10 /lung on the Y-axis and samples on the X-axis. At four weeks post infection
mean CFUs for Rv +Dox or RvΔglmU +Dox and RvΔglmU–Dox were 5.2, 0 and 5.11 on log10 scale.***p<0.0001, two tailed non parametric t-test, error bars
represent s.e.m. (E)Overall pathology (upper panel) and histopathology (lower panel, HE, 40X) of the infected guinea pig lungs four weeks post infection.
Both Rv +Dox and RvΔglmU -Dox were having prominent granuloma and necrotic lesions in the central and epithelioid cells and lymphocytes around it.
Guinea pigs infected with RvΔglmU +Dox were showing normal lung parenchyma with clear alveolar spaces. G = Granuloma, AS = Alveolar Space. (F)
Granuloma scores from histopathology results.
doi:10.1371/journal.ppat.1005235.g005
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efficient and equivalent implantation of both wild type and mutant bacilli in the lungs of guinea
pigs (Fig 5D). Discrete bacilli were observed in the lungs of guinea pigs infected with Rv and
RvΔglmU 28 days post-infection (Fig 5E and 5F). In contrast, the lungs of the guinea pigs
infected with RvΔglmU in the presence of doxycycline were clear (Fig 5E and 5F). In addition
splenomegaly was significantly reduced upon depletion of GlmUMtb (RvΔglmU + Dox; S2A
and S2B Fig). Whereas the bacillary load in the lungs and spleen of guinea pigs infected with
Rv and RvΔglmU were comparable, we did not detect any bacilli when the RvΔglmU infected
guinea pigs were administered Dox (Fig 5D). In accordance with these observations, while the
gross pathology of lungs infected with Rv and RvΔglmU displayed considerable granulomatous
architecture, normal lung parenchyma was observed upon GlmUMtb depletion (Fig 5E). These
results suggest that the presence of GlmUMtb is obligatory for mycobacteria to survive in the
host.
Depletion of GlmUMtb from infected lungs leads to clearance of pathogen
It was apparent from the data presented above that the addition of ATc or Dox at the time of
inoculation or at the time of infection does not allow mycobacterial cell growth or survival in
the host. In the ideal candidate for therapeutic intervention, inhibiting the activity of/ depleting
the enzyme at any stage of the infection should result in pathogen clearance. We assessed this
parameter of GlmUMtb by providing ATc at different stages of bacterial growth (early, log and
stationary phases) and investigating its influence on cell survival in liquid cultures. Addition of
ATc to RvΔglmU cultures on the 2nd, 4th or 6th day after inoculation significantly thwarted
growth (Fig 6A). A similar analysis of bacterial growth by serial dilution of cultures followed by
spotting on solid medium also revealed that viability was compromised by ~2 log fold 48 h
after the addition of ATc, indicating that GlmUMtb depletion negatively impacted cell survival
regardless of which stage of cell growth it was depleted at (S3A Fig).
The influence of GlmUMtb depletion on an established ex vivo infection was estimated by
providing ATc 24 h post-infection in a THP-1 infection model. As expected the bacillary load
in THP-1 cells infected with Rv and RvΔglmU were similar at 0 and 24 h after infection (Fig
6B). In contrast, while at 96 h post-infection the bacillary load for Rv and RvΔglmU- infected
THP-1 cells remained the same, the addition of ATc to RvΔglmU- infected THP-1 cells 24 h
after infection decreased the pathogen load by ~2.5 log fold, indicating that the reduction of
GlmUMtb levels impacts pathogen survival even in an established ex vivo infection (Fig 6B). We
extended this investigation to analyze the effect of GlmUMtb depletion from a fully-infected
lung using murine infection model. As anticipated, the bacillary load in the lungs of mice
infected with Rv and RvΔglmU were comparable both on Day 1 and on Day 28. Administration
of Dox to RvΔglmU infected mice for the next 56 days (Day 28 to Day 84) drastically decreased
the CFUs in the lungs (Fig 6C) and the pathogen was completely cleared from the spleen (S3B
Fig). Unlike the lungs of mice infected with Rv and RvΔglmU, mice infected with RvΔglmU to
whom Dox was administered displayed a total absence of lesions and granulomas in the lungs
(Fig 6D and 6E). Collectively, these data suggest a fundamental role for UDP-GlcNAc, the end
product of the GlmUMtb -mediated enzymatic reaction, in modulating the persistence ofMtb
infection.
Oxa33: A novel allosteric GlmUMtb inhibitor
In addition to the acetyltransferase and uridyltransferase active site pockets, GlmUMtb also con-
tains an allosteric site. Binding of any suitable molecule/inhibitor to the allosteric site would
prevent the conformational change essential for GlmUMtb uridyltransferase catalytic activity.
To target the allosteric site on GlmUMtb we drew on crystal structure data of H. influenza
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Fig 6. Depletion of GlmUMtb from infected lungs leads to clearance of pathogen. (A) Rv and RvΔglmU cultures were inoculated at an initial A600 of 0.1
and the growth was monitored every day for eight days. ATc was added to the Rv culture on day 2 and RvΔglmU cultures were either grown in the absence of
ATc or was supplemented with ATc in the growth media on 2nd, 4th or 6th day. Experiment was performed in triplicates and the error bars represent s.e.m. (B)
Differentiated THP-1 cells were infected Rv or RvΔglmU cultures and the infection was allowed to be established for 24 h. 24 h post infection ATc was
supplemented in the media for Rv and RvΔglmU infected cultures. As a control THP1 cells infected with RvΔglmU were grown without ATc. CFUs were
enumerated at 0, 24 and 96 h post infection. **p<0.005, two tailed non parametric t-test, Experiment was performed in triplicates and the error bars represent
s.e.m. (C) BALB/c mice (6 to 9 mice / group) were infected with Rv and RvΔglmU strains and the infection was established for next 28 days. Subsequently,
Dox was provided (with 5% dextrose on every alternate day) in the drinking water for Rv infected mice. One group of RvΔglmU infected mice were
administered with Dox and other with vehicle control for the next 56 days. CFUs were enumerated on day 1, day 28 and day 84 post infection. At 28th days
post infection mean CFUs for Rv and RvΔglmU infected mice were 4.43 and 4.47 on log10 scale and 84
th days post infection mean CFUs for Rv +Dox or
RvΔglmU +Dox and RvΔglmU–Dox were 5.1, 0.42 and 5.2 on log10 scale. ***p<0.0005, two tailed non parametric t-test, mean, error bars represent s.e.m.
(D)Overall pathology and histopathology of infected BALB/c mice lungs. Infected lungs dissected on 84th day after infection from Rv (+Dox) and RvΔglmU
(-Dox) infected mice shows clear lesions (upper panel) and granuloma with lymphocytes and foamy histiocytes (lower panel, HE stain, 100x) while RvΔglmU
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GlmU (GlmUHI) bound to its allosteric small molecule inhibitor (S4A and S4B Fig) [27]. Align-
ment of the GlmUMtb and GlmUHI allosteric pocket residues suggested that the interacting res-
idues were conserved between the two proteins (S4C and S4D Fig). The Asinex database was
screened against shape as described (S5A Fig) and the resulting 43 hits were biochemically
characterized for their ability to inhibit GlmUMtb uridyltransferase activity. One of the promis-
ing molecules was used for further structural optimization (S5A Fig). Of the 53 structurally
optimized compounds one molecule, namely (4Z)-4-(4-benzyloxybenzylidene)-2-(naphtha-
len-2-yl)-1,3-oxazol-5(4H)-one (Oxa33; Synthesis scheme provided in Figs 7A and S5B), was
found to be an efficient inhibitor of GlmUMtb activity with an IC50 of 9.96±1.1 μM (Fig 7B).
Isothermal titration analysis suggested an adequately high affinity binding for the compound
(Ka = 2.35×10
6 M-1), with a binding stoichiometry of 0.7 (S6A Fig). We sought to identify the
residues in GlmUMtb that are critical for interacting with Oxa33. Docking and MD simulation
studies revealed polar, non-polar and hydrophobic interactions between Oxa33 and the alloste-
ric site residues (Figs 7C, S6B and S6C). Based on the obtained data a panel of GlmUMtb pro-
teins each carrying a single mutation was created, the mutant proteins were purified (S6D Fig),
and their uridyltransferase activity assayed. While all the mutants had similar levels of uridyl-
transferase activity there was a substantial increase in their IC50 values, suggesting a loss of
interaction with Oxa33 (Fig 7D and 7E).
To decipher the mechanism of Oxa33 mediated inhibition of uridyltransferase activity, we
superimposed the GlmUMtb-Oxa33 complex with the unbound GlmUMtb structure. Upon
Oxa33 binding, the loop regions (in the range of 3–6 Å) at the uridyltransferase active site
undergo significant conformational changes, decreasing the active site volume, which results in
occlusion of the substrates (Fig 7F). Differential scanning fluorimetry (DSF) analysis of
GlmUMtb in the presence of Oxa33 showed a 3°C shift in protein melting temperature (Tm) val-
idating the conformational changes (S5E Fig). Interestingly we also observed much higher rela-
tive fluorescence units (~10000 vs 2500) in the presence of Oxa33, which is likely due to the
compound induced structural changes facilitating increased binding of the dye (S6E Fig).
Together, these data demonstrate that Oxa33 binds to the allosteric site at N-terminal domain
of GlmUMtb and inhibits its uridyltransferase activity by causing structural changes.
Specificity and efficacy of Oxa33
Subsequently we investigated the ability of Oxa33 to inhibit the in vitro growth ofMtb H37Rv.
Oxa33 inhibited the in vitro growth ofMtb H37Rv with a minimum inhibitory concentration
(MIC) of ~75 μM (~30 μg / ml) and a maxium bacteriocidal concentration (MBC) of ~150 μM
(~60 μg / ml). To ascertain if this inhibitory effect was due to inhibition of GlmUMtb activity we
overexpressed GlmUMtb in the cells prior to drug treatment and determined the effect of this
on the MIC value (Figs 8A and S6A). Whereas the inhibition of growth in the presence of INH
was similar with or without GlmUMtb overexpression in the cells (Fig 8A, lower panel), Oxa33
failed to inhibit cell growth even at concentrations as high as 150 μM (60 μg/ ml) (Fig 8A,
upper panel). Interestingly when sub lethal concentration of Oxa33 was provided, the MIC of
INH decreased from 32 to 16 ng/ml (S7B Fig). The impact of Oxa33 on THP1 cells 24 h after
infection with either Rv or Rv::glmUtet-on was also investigated. In concurrence with the in vitro
growth data, overexpression of GlmUMtb alleviated Oxa33-mediated clearance ofMtb from
THP-1 cells (Figs 8B, S6D and S6E). These results suggest that the inhibition of mycobacterial
growth by Oxa33 is specifically due to inhibition of endogenous GlmUMtb.
(+Dox) was showing normal lung parenchyma and no granuloma. G = Granuloma, BL = Bronchial Lumen, AS = Alveolar Space. (E)Granuloma scores from
4 and 12 weeks of histopathology results.
doi:10.1371/journal.ppat.1005235.g006
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Finally, we analysed the efficacy of Oxa33 in clearing bacilli from infected lungs using a
murine infection model. Oxa33 compound is highly hydrophobic in nature. After trying many
solvents, we could successfully resuspend it in 2.5% Tween-80. Prior to performing the experi-
ments we examined the maximum dose tolerance and survival analysis to determine the toxic-
ity (S8A and S8B Fig). Based on the data obtained we chose 50 mg / kg as the appropriate dose.
Fig 7. Oxa33, a novel inhibitor against GlmUMtb binds at allosteric site of uridyltransferase domain. (A) Synthetic scheme for the preparation of 4-(4-
(benzyloxy)benzylidene)-2-(naphthalen-1-yl)oxazol-5(4H)-one (Oxa33). (B) IC50 values were determined by varying the concentration of Oxa33 and
calculating the percent activity with respect to the uridyltransferase activity of 0.75 pM conc GlmUMtb in the presence of 5% DMSO (vehicle). IC50 value was
calculated by plotting percentage activities against different log10 values of inhibitor concentrations (μM). Experiment was performed in triplicates and the
error bars represent s.e.m. (C) Left panel depicts docking surface representation of the allosteric site on the of the GlmUMtb allosteric site in complex with
Oxa33. Right panel represents ribbon cartoon showing the amino acids residues of allosteric site and hinge region interacting with Oxa33 (in ball and stick
model). Tyr150, Glu250 and Arg 253 were found to be in hydrogen bonding with carbonyl oxygen over the oxazole ring. While Leu144, Pro147, Phe148,
Tyr150, Ala233, Ala236 and Leu247 participate in strong hydrophobic interactions with Oxa33. (D) Based on the data above GlmUMtb allosteric site mutants
were created, proteins were purified and the uridyltransferase activity of GlmUMtb mutants was determined. Wild type and mutant GlmUMtb proteins show
almost comparable activity. (E) IC50 values in μMwere determined as described above for the wild type and the mutant GlmUMtb proteins. Tables shows the
values obtained for wild type and mutant enzymes. Experiments were performed in triplicates and the error bars represent s.e.m. (F) Superimposed view of
GlmUMtb-Oxa33 complex before (green) and after (orange) the simulation time period. Showing a partial closure of uridyltransferase site (decreased volume)
thereby making it unavailable for its substrates for catalysis.
doi:10.1371/journal.ppat.1005235.g007
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Fig 8. Specificity and efficacy of Oxa33. (A) Rv and Rv::glmUtet-on cultures were grown in presence of 1 μg/ml ATc and different concentrations of Oxa33
or INH (as indicated). 0.02% resazurin dye was added on day 7. Pink colour indicates viable bacteria while blue colour indicates dead bacteria. ‘C’ denotes
culture media control. The experiment was performed thrice. (B) Differentiated THP1 were infected either with Rv or Rv::glmUtet-on and grown in RPMI media
containing 400 ng/ml ATc. 24 h post infection different concentrations (as indicated) of Oxa33 or vehicle control was supplemented to the media for the next
72 h followed by CFU enumeration. Experiment was performed in triplicates and the error bars represent s.e.m. (C) BALB/c mice (7 to 11 mice / group) were
infected with Rv and the infection was allowed to be established for 28 day. Oxa33 (50 mg/kg, intraperitoneal, in 2.5% Tween 80) or INH (25 mg/kg, in
drinking water with 5% sucrose) were administered to the mice for a subsequent period of 56 days. CFU in the lungs of mice were determined on 1, 28 and 84
days post infection. Day 1st and day 28th CFUs show successful implantation and establishment of infection, respectively. 56 days of Oxa33 or INH treatment
partially reduces the mean bacillary load to 2.78 and 1.3 on log10 scale. ***p<0.0005 or 0.0006, two tailed non parametric t-test, error bars represent s.e.m.
(D)While the overall pathology of lungs (upper panel) illustrates robust Mtb infection in untreated mice, relatively smaller and fewer lesions and granulomas
were observed in Oxa33 or INH treated mice. Lower panel exhibit hematoxylin and eosin stained photomicrograph of lungs from Rv, INH treated and Oxa33
treated mice at 100x magnification. This histopathological analysis shows large or small granuloma with lymphocytes and foamy histiocytes in Rv infected
mice or Oxa treated mice respectively G = Granuloma, BL = Bronchial Lumen, AS = Alveolar space. (E)Granuloma scores from lungs of infected and treated
mice for 4 weeks and 12 weeks.
doi:10.1371/journal.ppat.1005235.g008
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Since it was difficult to predict the fate of Oxa33 during the process of digestion, we avoided
using the oral administration route. We chose intra peritoneal route for administering the
compound as the intravenous (I/V) injection of Tween 80 (solvent) in the animals was known
to cause hypersensitivity and anaphylactic shock [45,46].
Groups of mice were infected with Rv and were treated with vehicle, INH, or Oxa33 at 28
days post-infection, for a duration of 56 days (Fig 8C, line diagram). Compared with the vehi-
cle-treated group where we observed a marginal increase in bacillary load, a significant reduc-
tion in the bacillary load was observed in the lungs and spleen of both, INH- and
Oxa33-treated groups (~4 and 2.5 log fold, respectively for lungs) (Figs 8C and S9A). This was
also reflected in the gross pathology and histopathology of lungs (Fig 8D and 8E). Although in
vitroMBCvalues of Oxa33 was ~150 μM (60 μg/ml), it seems to be a relatively more efficacious
in vivo, which could be due to its accumulation in the lungs of the infected mice. To investigate
this possibility uninfected mice were treated with 50 mg/kg Oxa33 for a period of 3 weeks or 8
weeks. In order to estimate the concentration of Oxa33 in the lung, we first determined the
absorbance spectra for Oxa33, which gave a clear peak at 401 nm (S10A Fig). We determined
the A401 at different concentrations of Oxa33 and the standard curve was plotted (S10B and
S10C Fig). Oxa33 was extracted from the lungs and its concentration was determined. The con-
centrations of Oxa33 in the lungs were in the range of ~200–300 μg /lung at 3 weeks and ~800–
1300 μg/lung at 8 weeks (S10D Fig). The accumulation of Oxa33 in the lungs is ~13 to 18 fold
higher than the MBC values, which may be the reason for higher potency of Oxa33 in vivo
compared with the in vitro experiments. Taken together, the results presented in this study
establish GlmUMtb to be an effective target against which new sets of inhibitors may be
developed.
Discussion
Cell wall provides the structural rigidity and protects bacteria from various environmental and
physiological insults. Biosynthesis of the cell wall of bacteria is a complex process requiring
enzymes localized to different cellular compartments [47]. Due to the essentiality of the
enzymes involved they are considered attractive targets for anti-microbial therapies. The
majority of the first line and second line anti-tuberculosis drugs from the existing regimen tar-
get enzymes involved in cell wall synthesis [5]. These include Isoniazid and Ethionamide tar-
geting enoyl-[acyl-carrier-protein] reductase and inhibiting mycolic acid synthesis,
Ethambutol targeting arabinosyl transferase and inhibiting arabinogalactan biosynthesis, and
Cycloserine targeting D-alanine racemase and ligase, which inhibits peptidoglycan synthesis
[5]. However most of these drugs are not very effective against dormant/ latentMtb [48].
UDP-GlcNAc is a critical metabolite both in prokaryotes and eukaryotes. In eukaryotes it is
mainly utilized for O- or N- GlcNAcylation, sialic acid biosynthesis and hylauronic acid bio-
synthesis [49–51]. In addition to the peptidoglycan synthesis [10], in gram negative bacteria
UDP-GlcNAc is required for the synthesis Lipid A subunit of lipopolysaccharide [52] and in
gram positive bacteria it is required for Rha-GlcNAc linker [53], arabinogalactan [54], teichioc
acid synthesis [55]. In few prokaryotes, UDP-GlcNAc has also been shown to be required for
sialic acid [56], N-GlcNAcylation [57] and poly (-GlcNAc-)n [58]. GlmUMtb, an enzyme with
dual activity, synthesizes a core metabolite necessary for the synthesis of cell wall peptidogly-
can, UDP-GlcNAc [6]. Interestingly, we found that depleting GlmUMtb during both normoxic
and hypoxic growth resulted in substantial decrease in cell viability (Fig 3). This may be due to
the requirement of UDP-GlcNAc, which in addition to participating in cell wall synthesis is
also required for other cellular processes such as mycothiol biosynthesis (to maintain redox
homeostasis) [14,59]. However, the TEM data clearly shows decreased cell envelop thickness
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even in hypoxic conditions (Fig 3). Although the CFUs do not change significantly the cells
may be undergoing significant replication, which might be balanced by death [60]. Alterna-
tively, new cell envelop may be required even if the bacteria are not replicating. Thus one can
rule out the possibility that decreased viability may well be due to requirement of UDP-GlcNAc
for the cell envelop synthesis.
While UDP-GlcNAc is a critical metabolite for both prokaryotes and eukaryotes, the
enzymes involved in its de novo synthesis are significantly different [10]. In addition, both pro-
karyotes and eukaryotes can utilize GlcNAc from different sources to synthesize UDP-GlcNAc
through salvage pathways [61–63] (S11 Fig). Capnocytophaga canimorsus, a member bacteria
from Bacteroidetes phylum lacks endogenous GlmM and GlmU required for the synthesis of
GlcNAc and it instead relies on GlcNAc obtained from forages glycans from the host mucin
and N-linked glycoproteins [42]. Depending on the enzymes of the salvage pathway present in
the bacterial system, it would require either both the activities or only the uridyltransferase
activity of GlmUMtb for UDP-GlcNAc synthesis. Till date the presence of alternate salvage
pathway inMtb has not been demonstrated. However, even with an operating salvage pathway
GlmUMtb is essential for the utilization of host GlcNAc to form UDP-GlcNAc (S11 Fig). In line
with this, we find that depletion of GlmUMtb during ex vivo or in vivo infection either at the
start or after infection has been definitively established leads to clearance of pathogen.
GlmUMtb and the acetyltransferase and uridyltransferase enzymes found in eukaryotes
share very little sequence similarity. Although efforts have been made by different groups to
target bacterial GlmU proteins, the specificity of these inhibitors for GlmU in vivo have not
been established [23–30]. Most GlmU inhibitors characterized till date target either the acetyl-
or uridyltransferase active sites. In contrast, inhibitors of GlmUHI target the allosteric site near
the uridyltransferase active site [27]. The interaction of the inhibitor with the enzyme via this
allosteric site perturbs the active site conformation of the protein, thus inhibiting uridyltrans-
ferase activity [27]. In the present study we have used shape based designing and developed a
novel oxazolidine molecule, Oxa33, and characterized its ability to bind to the GlmUMtb allo-
steric site. MD simulation and mutation of critical interacting residues to defined the possible
allosteric site residues required for Oxa33 binding (Fig 7). DSF (S6E Fig) and structural super-
imposition (Fig 7) supports that inhibition of uridyltransferase activity is due to structural
changes in the N-terminal domain of GlmUMtb. Further in order to determine the specificity of
Oxa33, GlmUMtb over expressing strains of Rv was used to determine the MIC. Both in vitro
and ex vivo results (increased MIC or MBC) validate that Oxa33 specifically binds to GlmUMtb
inside the bacteria. Administrating the Oxa33 to fully infected (28 days) mice resulted in partial
ablation of pathogen load in the lungs. Taken together results presented here demonstrates
that GlmUMtb is a viable and promising target for therapeutic intervention and Oxa33 can be
pursued as a lead molecule, which needs to be developed further to improve its efficacy.
Materials and Methods
Chemicals and reagents
Restriction enzymes and Phu DNA polymerase were purchased from New England Biolabs.
pENTR/directional TOPO cloning kit (Invitrogen), pQE2 (Qiagen), were procured from the
respective sources. Analytical grade chemicals and oligonucleotide primers were procured
from Sigma. Malachite green phosphate assay kit (POMG-25H) was purchased from BioAssay
System (Gentaur). Electron microscopy reagents were purchased from Electron Microscopy
Sciences. Media components were purchased from BD Biosciences. Doxycycline hydrochloride
was purchased from Biochem pharmaceutical.
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Generation of glmU conditional gene mutant inM. tuberculosis
The hexa-His tag in the pST-KiT construct[15] was replaced with an N-terminal FLAG tag,
and the tetracycline repressor gene (tetR) was replaced with a reverse tetR (r-tetR) from
pTC28S15-OX [64] to create plasmid pST-KirT. To generate the integrating shuttle plasmid
pST-KirT-glmUMtb, the glmUMtb gene was excised from pQE2-glmUMtb using NdeI-HindIII
digestion and was subcloned into the corresponding sites on pST-KirT. The resulting
pST-KirT-glmU construct expresses GlmUMtb in the absence of inducer ATc. Upon addition of
ATc, ATc binds to the r-TetR repressor resulting in the conformational change that would
allow it to bind to the operator seqeunces in PmyctetO (S1 Fig) [64]. The integration-proficient
plasmid containing the inducible glmUMtb gene was electroporated into mycobacterial cells to
create the merodiploid strain Rv::glmUMtb. 5’ and 3’ genomic flank sequences of glmUMtb
(approximately 1 kb on either side) were amplified, the amplicons digested with PflMI, and
ligated with the antibiotic resistance cassette along with the oriE and cosλ fragments generated
from pYUB1474 construct, to generate the allelic exchange substrate (AES) [65]. The AES was
linearized using the unique PacI site and then cloned into temperature sensitive shuttle phage-
mid phAE159 at the PacI site. A conditional gene replacement mutant of RvΔglmU was created
from the merodiploids with the help of specialized transduction methodology (S1A Fig) [66].
RvΔglmU recombinants obtained were analyzed by PCR amplification to verify the fidelity of
the recombination event.
Analysis of growth patterns
H37Rv (Rv) and RvΔglmU cultures were grown in Middlebrook 7H9 medium supplemented
with 10% ADC (albumin, dextrose and catalase), or in 7H11 medium supplemented with 10%
OADC (oleic acid, ADC). To analyze bacterial growth in vitro, Rv and RvΔglmUmutant bacte-
rial cultures were inoculated at A600 of 0.1, in the presence or absence of anhydrotetracycline
(ATc), and A600 was measured every 24 h for 6 or 8 days. For spotting analysis, cells were har-
vested by centrifugation, washed twice with PBST (0.05% Tween 80) to remove ATc, resus-
pended in 7H9 medium, and serially diluted in the same medium, followed by spotting 10 μl
aliquots of the various cell dilutions on 7H11 agar plates to assess cell viability. To determine
the impact of GlmUMtb depletion during hypoxia in Rv and RvΔglmU strains, we established
hypoxia in 1.5 ml HPLC tubes or 500 ml flasks with penetrable caps, following modified
Wayne model [35]. ATc (2 μg/ml) or isoniazid (INH) (50 ng/ml) were injected into the cultures
at different time points and the number of CFUs were determined after 42 days. Scanning and
transmission electron microscopy (SEM & TEM) analysis of Rv and RvΔglmUmutant grown
in the presence or absence of ATc were performed as described earlier [67]. Transmission elec-
tron microscopy was performed using standard protocols. Briefly, bacteria was fixed in 2.5%
gluteraldehyde and 4% paraformaldehyde, dehydrated in graded series of alcohol and embed-
ded in Epon 812 resin. Ultrathin sections were cut and stained with uranyl acetate and lead cit-
rate [68]. SEM images were procured using Carl Zeiss Evo LS scanning electron microscope,
and TEM images were captured using Tecnai G2 20 twin (FEI) transmission electron
microscope.
Generation of glmUMtbmutant constructs and western blotting analysis
Site directed mutations of glmUMtb were generated with the help of overlapping PCR and the
amplicons were cloned into NdeI-HindIII sites of pQE-2, pNit and pST-KT vectors [15,69].
The tetracylin repressor (TetR) expressed from the plasmids binds to the operator sequence in
the promoter PmyctetO in the absence of ATc (S1B Fig) [70]. Addition of ATc to TetR alleviates
the repression thus inducing the expression of GlmU. pST-KT-glmU was electroporated into
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Rv to generate Rv::glmUtet-on strain. pNit-glmU (wild type and mutated) constructs were elec-
troporated into RvΔglmU to generate RvΔglmU::glmUwt/mutant strains. Rv and RvΔglmU::
glmUwt/mutant strains were grown in the presence or absence of ATc as described above.
GlmUMtb was expressed and purified using plasmid pQE2-GlmUMtb, as described earlier [15].
Whole cell lysates (WCL) isolated from Rv, RvΔglmU and RvΔglmU::glmUwt/mutant strains that
had been grown for 5 days in presence or absence of Atc, were resolved on 10% SDS-PAGE,
transferred to nitrocellulose membrane, and probed with anti-GlmUMtb and anti-GroEL1 anti-
bodies as described earlier [15,67].
Ex vivo and in vivo infections
THP1 infection experiments were carried out with either unlabelled or FITC-labelled Rv and
RvΔglmU strains at 1:10 MOI, as described earlier [71]. For examination of cells under a fluo-
rescence microscope, infected cells (48 h post-infection) were labelled with Lyso Tracker red
DND 99 dye (50 nM) and mounted with Antifade (Invitrogen) mounting agent. To determine
CFUs per infected cell, the infected cells were lysed in PBS containing 0.1% TritonX-100 for 15
min and different dilutions were plated on OADC-containing 7H11 agar plates. For animal
infection experiments, Rv and RvΔglmU strains grown till A600 of 0.6 were used to infect 3 to 4
week old guinea pigs or ~ 2 month old mice as described previously [72,73]. We initially used
guinea pig model system as it has robust immune response. However, for the remaining experi-
ments we chose to use Balb/C mice model of infection as the cost associated with performing
the experiments and the amount of Oxa33 required for guinea pig experiments was prohibitive.
To determine the implantation dosage, the bacillary load in the lungs of guinea pigs or mice
was determined 24 h post-infection. To investigate the impact of glmUMtb depletion on survival
of the pathogen, doxycycline hydrochloride (Dox, 1 mg/ kg with 5% dextrose in drinking
water) was provided to Rv and RvΔglmU-infected animals as indicated, either from the time of
the infection (guinea pig experiment), or 4 weeks post-infection (mice infection experiments).
To assess the impact of INH or Oxa33 treatment on pathogen survival, Rv-infected mice (4
weeks post-infection) were supplied with INH (25 mg/ kg body weight, with 5% dextrose in
drinking water) or Oxa33 (50 mg/ kg body weight, with 2.5% Tween 80, injected intra peritone-
ally) every third day for 8 weeks. Bacillary loads in the lungs and spleens of infected guinea pigs
and mice were determined 4 weeks and 12 weeks post-infection. Histopathological evaluation
of the harvested organs was performed as described earlier [67,72,73].
Shape based screening and molecular docking studies
ROCS (Rapid Overlay of Chemical Structures), a shape based technique for rapid similarity
analysis was used to assess the compounds. Gaussians and shape tanimoto were used to assess
the volume and shape overlaps of the compounds, respectively. As the chemical functionality is
critical, the chemical feature based similarity was also considered using ROCS colour score
whose force field was composed of SMARTS patterns of the chemical functions [74,75]. The
shape tanimoto score and scaled color score were considered during the selection of the com-
pounds for further virtual screening. The compounds selected were subjected to molecular
docking studies using Glide v5.8 of Schrödinger molecular modelling suite 2012 (Glide v5.8,
Schrödinger). The compounds were subjected to a series of docking protocols–high throughput
virtual screening (HTVS), standard precision (SP) and extra precision (XP) docking. As the
docking progresses from HTVS to XP, the algorithm differs, which starts from a simple dock-
ing of compounds and ends with docking protocol with high precision and parameterization
while cutting off the number of compounds.
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Synthesis of 4-(4-(benzyloxy)benzylidene)-2-(naphthalen-1-yl)oxazol-5
(4H)-one
To the glycine solution (3.0 g, 39.89 mmol) in water under constant stirring at 0°C, NaOH
(3.19 g, 79.78 mmol) was added. This was followed few minutes later by the addition of
1-naphthoyl chloride (7.20 mL, 47.86 mmol) in 1, 4-Dioxane (20 ml) and the contents were
stirred at room temperature for 6 h. The reaction mixture was concentrated to half the volume
and 60 ml EtOAc was added. The EtOAc layer was washed with sat NaHCO3 (2 × 30 mL) fol-
lowed by H2O (2 × 20 mL). The separated organic layer was dried and concentrated over anhy-
dro Na2SO4 to obtain solid compound, which was washed with hexanes to get 2-
(1-naphthamido) acetic acid (8.30 g, 90%) as a white solid (M.P. 152°C1). 2-(1-naphthamido)
acetic acid (2.0 g, 8.73 mmol), NaOAc (0.21 g, 2.62 mmol) and 4-benzyloxybenzaldehyde (1.85
g, 8.73 mmol) were taken in acetic anhydride and heated at 106°C for 3 h. The solid formed
were filtered and washed with water to remove traces of acetic anhydride, and ethanol to
remove unreacted aldehyde and other organic impurities. Final compound 4-(4-(benzyloxy)
benzylidene)-2-(naphthalen-1-yl)oxazol-5(4H)-one (Oxa33; 3.14 g, 88%), purified as a yellow
solid, was confirmed with nuclear magnetic resonance (NMR) [76].
Isothermal titration calorimetry
To investigate the binding of Oxa33 to GlmUMtb, we performed Isothermal Titration Calorim-
etry (MicroCal 2000 VP-ITC, GE Healthcare) [28]. Oxa33 was re-suspended in dialysis buffer
(25 mM Tris pH 7.4, NaCl 140 mM and 15% glycerol), 100 μM of MgCl2 containing 2%
DMSO. 625 μM of Oxa33 was injected for titrations from syringe (rotating at 307 rpm) into
ITC cell containing 25 μM of GlmU or blank buffer at 25°C. Each injection lasted for 20 sec
with 300 sec interval between every step. The quantity of heat associated by every injection was
calculated by combining the area beneath every heat burst curve (microcalories/second vs. sec-
onds). Data was corrected for the buffer signal and fitting was done by one-site binding model.
Origin software (version 7.0) was used to obtain different thermodynamic binding parameters.
In vitro cytotoxicity
Oxa33 was evaluated for its cytotoxic activity in THP1 cells with the help of alamar blue assay.
Serially diluted inhibitors (in 2.5% DMSO) incubated with 5 x 103 differentiated THP-1 cells in
96 well plates for 3 days. After 3 days cells were incubated for 5 h with 10 μl of alamar blue and
color development was measured using micro-plate reader at 570 nm.
Docking and molecular dynamics simulations studies of GlmUMtb with
Oxa33
Molecular dynamics (MD) simulation for the protein-ligand complex was carried out for a
time scale of 20 ns so as to analyze the stability of molecular interactions between ligand and
protein employing Newton’s Laws of Motions. Desmond molecular dynamics system v3.1 was
used for carrying out the simulations employing OPLS-AA force field [77]. The protein-ligand
complex was solvated using TIP3P water model which was setup as an orthorhombic solvent
box, keeping a cut-off of 10 Å from any solute atom in all directions [78]. Na+ counter ions
were added in order to neutralize the system. A cut-off of 14 Å was maintained for calculating
the solvent-solvent and solute-solvent non-bonded interactions. Initially, the system was mini-
mized keeping the convergence threshold criteria of 1.0 kcal.mol-1.Å-1 so as to allow the adjust-
ment of atoms to the system environment. A simulation for each system was performed using
isothermal-isobaric ensemble (NPT) including a relaxation process. Under NPT, the system
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was simulated for 12 ps using a Berendsen thermostat and a Berendsen barostat with tempera-
ture of 10K and a pressure of 1 atm. The later step of relaxation protocol included the simula-
tion of the system for 24 ps with a temperature of 300 K and 1 atm pressure with and without
restraints on solute heavy atoms. M-SHAKE algorithm was used with an integration time step
of 2 fs for rearranging the hydrogen bonds in the simulation [79]. The temperature and pres-
sure of the system were maintained at 300 K and 1.013 atm respectively. The molecular dynam-
ics simulation was run for 20 ns recording the trajectory frames at an interval of every 4.8 ps
and the trajectory analysis was carried out using the Simulation Event Analysis of Desmond.
Determination of percentage inhibition, IC50 and MIC
Uridyltranferase assays were performed using malachite green phosphate detection kit as
described previously [17]. Acetyltransferase activity of GlmUMtb was carried out in the pres-
ence of 500 μM each of GlcN-1-P and acetyl-CoA in a 30 μl reaction volume for 30 min at
30°C as described earlier [80]. To determine the percent inhibition by different compounds the
enzyme was preincubated with either 5% DMSO or 100 μM compounds for 30 min prior to
performing uridyltransferase activity assays. In order to determine the IC50 values, GlmUwt/
mutant proteins were preincubated with different concentrations of Oxa33 compound for 30
min followed by the uridyltransferase assay. To determine minimum inhibitory concentration
(MIC), 5x105 bacteria of Rv or Rv::glmUtet-on (overexpressing GlmUMtb) cultures (grown in the
presence or absence of 2 μg/ml ATc) were mixed with 100 μl of 2.5% DMSO or different con-
centrations of Oxa33/ INH in 96-well plates, and incubated at 37°C for 6 days. After 6 days,
40 μl of resazurin dye (0.02% in 5% Tween-80) was added to each well and the colour change
was observed after 12 h.
Ethical statement
Experimental protocol for the animal experiments was approved by the Institutional Animal
Ethics Committee of National Institute of Immunology, New Delhi, India (the approval num-
ber is IAEC# 315/13). The approval is as per the guidelines issued by Committee for the Pur-
pose of Control and Supervision of Experiments on Animals (CPCSEA), Govt. of India.
Statistical analysis
Student’s t-test (two tailed non parametric) was used to analyze the significance of cell wall
thickness, THP1 and animal infection experimental results. SigmaPlot version 10.0 and Graph-
Pad Prism version 5.0 was used for the statistical analysis and for plotting the results.
Supporting Information
S1 Text. Supplementary Methods and Results. Designing and development of allosteric site
inhibitors of GlmUMtb. Screening of inhibitors. Isothermal Titration Calorimetry. Docking and
molecular dynamics simulations. H-bond analysis. Survival curve and maximum dose toler-
ance. Estimation of Oxa33 from treated mice lungs.
(DOC)
S1 Fig. Schematic representating regulation of Tet-off (A) and Tet-on systems (B).
(TIF)
S2 Fig. Effect of GlmUMtb depletion on spleen during guinea pig infection. Guinea pigs (six
per group) were infected with Rv or RvΔglmU and Dox was provided in the water as indicated
in Fig 5. (A)Overall pathology of the infected spleens from the guinea pigs 4 weeks post
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infection. (B) CFU data from guinea pig spleens. p<0.0001 or, two tailed non parametric t-
test, mean, error bars indicate s.e.m.
(TIF)
S3 Fig. Depletion of GlmUMtb from infected spleen or any stage of growth leads to clear-
ence of pathogen. (A) Rv and RvΔglmU cultures were inoculated at an initial A600 of 0.1. ATc
was added to the Rv culture on day 1 (a) and RvΔglmU cultures were either grown in the
absence of ATc or was supplemented with ATc in the growth media on 1st (a), 3rd (b) or 5th (c)
day. Serially diluted cultures were spotted on 7H11 agar plates after day 1, 3, 5 and 7. The
experiment was performed in triplicates. (B) BALB/c mice (6 to 9 / group) were infected with
Rv and RvΔglmU strains. 28 days post infection Dox was provided for Rv and RvΔglmU
infected mice and one group of RvΔglmU infected mice were administered with the vehicle
control for the next 56 days. CFUs were enmurated from the spleens of infected mice on day 28
and day 84 post infection. At 28 days post infection mean CFUs for the spleens of Rv and
RvΔglmU infected mice were 2.9 and 3.15 on log10 scale and 84 days post infection mean CFUs
for Rv +Dox or RvΔglmU +Dox and RvΔglmU–Dox infected spleens were 3.67, 0 and 3.5 on
log10 scale. p<0.0005, two tailed non parametric t-test, error bars indicate s.e.m.
(TIF)
S4 Fig. Structural comparision ofH. influenzae andMtb allosteric site. (A) Surface represen-
tation of GlmUHI wherein its allosteric residues are highlighted. The allosteric site of GlmUHI,
comprises of highly lipophilic surface and a distal depression surface. (B) Interction of GlmUHI
allosteric inhibitor at the allosteric site. Hydrophobic residues are coloured in green, polar resi-
dues in blue, negatively charged residues in red. Hydrogen bond interaction of the ligand with
Gln231 is shown in pink color; Glu224 is also involved in the hydrogen bonding which is not
represented here. Leu133, Tyr139, Met221, Leu235 were found to be involved in strong hydro-
phobic interactions with the inhibitor. Interactions were plotted with LIGPLOT. (C) Sequence
alignment of GlmUHI and GlmUMtb allosteric site residues. Conserved residues are highlighted
in red boxes. (D) Table displaying allosteric residues of GlmUHI and GlmUMtb. Some of the
critical residues such as Tyr150, Gln243 and Leu247 of GlmUMtb are seen to be conserved.
(TIF)
S5 Fig. Design, development and synthesis of anti-GlmUMtb inhibitor. (A) Virtual screening
workflow used towards the identification of allosteric inhibitors for GlmUMtb. Shape model of
allosteric inhibitor of GlmUHI was generated using ROCS software. In the initial set of screen-
ing, a total of 43 compounds were identified and tested for their ability to inhibit uridyltransfer-
ase reaction. 10 among the 43 compounds showed ~90% inhibition at 100 μM. Of these, an
oxozolone derivative was identified and further chemically derivatized to a library of 52 com-
pounds. One compound from these, Oxa33, which showed ~90% inhibition was considered for
further studies. (B) Nuclear magnetic resonance spectra of purified Oxa33 (Yellow solid). 1H
NMR (400 MHz, CDCl3): δ 9.51 (d, J = 8.8 Hz, 1H), 8.38 (d, J = 8.8 Hz, 1H), 8.25 (d, J = 8.4 Hz,
2H), 8.10 (d, J = 8.4 Hz, 1H), 7.93 (d, J = 8.0 Hz, 1H), 7.74 (t, J = 8.0 Hz, 1H), 7.68–7.56 (m,
2H), 7.49–7.33 (m, 5H), 7.29 (s, 1H), 7.12 (d, J = 8.4 Hz, 2H), 5.15 (s, 2H). Anal calcd for:
C27H19NO3: C, 79.98; H, 4.72; N, 3.45% Found C, 79.92; H, 4.83; N, 3.54%.
(TIF)
S6 Fig. ITC, MD simulation and DSF studies of Oxa33. (A) Isothermal titration calorimetry
results of Oxa33 with GlmUMtb. Released heat increased over the period of time (μcal/sec) is
presented in upper panel while corresponding binding isotherm (fitted for one site) presented
in lower panel. (B) rmsd plot for GlmUMtb-oxa33 complex simulated for a period of 20ns. The
complex was found to be unstable during the initial time period which can be owed for its
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relaxation. After 8 ns, the complex was observed to be stable indicating the strong binding
affinity of Oxa33 towards GlmUMtb (C)Hydrogen bond analysis of Oxa33 analyzed during the
simulation time period. (D) Purified GlmUMtb mutants (single band) specified by the docking
studies of Oxa33. (E) Differential Scanning Fluorimetry (DSF; performed in triplicates) results
of Oxa33 with GlmUMtb. Left panel representing melting curve of GlmUMtb in presence of 5%
DMSO. While right graph is showing -3°C Tm shift upon Oxa33 incubation with GlmUMtb
protein.
(TIF)
S7 Fig. GlmUMtb overexpression, cytotoxicity and effect of INH upon Rv or overexpressing
strains. (A) Rv and Rv::glmUtet-on strains were inoculated at an initial A600 of 0.1 in the pres-
ence of ATc (2 μg/ml) and grown up to 5 days. WCLs were resolved and probed with anti-
GlmU and anti-GroEL1 antibodies. (B) Rv culture was treated with sub lethal dose of Oxa33
(40 μM) and variable concentrations of INH for 6 days followed by resazurine addition. Results
show decrease in MICs of INH from 32 ng/ml to 16 ng/ml. The experiment was pefromed in
triplicates. (C) Bar graph presents the cytoxicity of the Oxa33 on THP1 cells during the 3 days
of treatment. Cell viability was checked with alamar blue based assay and absorbance at 570
nm was plotted with increasing concentrations of Oxa33 inhibitor. The experiment was per-
formed in triplicates and the error bars represent s.e.m. (D) CFUs count results of THP1 cells
infected with Rv (for 24 h post infection) followed by treatment with various concentrations of
INH (in water) for 3 days. CFU (log10) per well shows gradual increase in bacterial death with
increasing INH doses. p<0.005, two tailed non parametric t-test, mean, s.e.m., n = 3). (E)
Graph illustrate CFU numbers from fully infected THP1 cells (24 h) with Rv:: glmUtet-on. Abun-
dant GlmUMtb expression in Rv::glmUtet-on infected THP1 cells (with ATc) does not affect INH
efficacy, which gives similar results as Rv. p<0.005, two tailed non parametric t-test,. error
bars represent s.e.m.
(TIF)
S8 Fig. Dose tolerance and mice survival curves. (A)Maximum dose tolerance graph showing
relative change in body weight of mice (4 mice / group) during the course of Oxa33 administra-
tion for 30 days. (B) Survival curve of mice (4 mice / group) treated with different concentra-
tions of Oxa33 for 30 days.
(TIF)
S9 Fig. In-vivo efficacy onMtb load in infected mice spleen and toxicity of Oxa33. (A)Mtb
bacterial load in the spleen of totally infected mice (7 to 11 mice /group) (for 28 days) and
treated with Oxa33 or INH for subsequently 56 days. p<0.0007 or p<0.002, two tailed
non parametric t-test, the error bars represent s.e.m. (B)High power (400x) photomicrograph
of hematoxylin and eosin stained spleen, brain, heart, liver and lungs of untreated mice or mice
treated with Oxa33 for 8 weeks. Spleen is showing usual parenchyma. WP =White Pulp,
RP = Red Pulp. While, section from hippocampal area of brain showing several degenerated
neuron in the neuronal layer. Section of heart is showing normal cardiac muscle fibres. Photo-
micrograph of liver depicts typical hepatic parenchyma. PV = Portal Vein, BD = Bile Duct.
Lung section also represents usual lung parenchyma. BL = Bronchial Lumen, AS = Alveolar
space.
(TIF)
S10 Fig. Standard curve for Oxa33 and its estimation in treated mice lungs. (A) Absorbance
spectra of Oxa33 resuspended in tetrahydrofuran (THF). It showed a peak at 401 nm. (B)
Absorbance readings (401 nm; performed in triplicates; A, B and C) of Oxa33 at different con-
centrations (C) Standard curve of Oxa33 showing linear regression with a slope of 0.0497 OD /
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μg. (D) Table showing Oxa33 concentrations (μg/lung) in the lungs of mice treated with 50 mg
/kg (body weight) for 3 or 8 weeks.
(TIF)
S11 Fig. Model for the UDP-GlcNAc synthesis pathways inMtb.Model shows De novo path-
way for UDP-GlcNAc synthesis is mediate by GlmS, GlmM and GlmU enzymes. Shaded path-
way is conserved inMtb. UPD-GlcNAc can inhibit uridyltransferase activity by feedback
inhibition mechanism. Also GlcNAc from host resources or from cell wall recycling can be
transported inside the bacteria and further metabolized and feeded into the de novo pathways
through GlmS/ GlmUmediated reactions. Question marks show that these pathways are still
not characterized inMtb. Dashed lines shows possible input of substrates or unknown pathway
while complete lines shows established and known pathways for UDP-GlcNAc synthesis.
(TIF)
S1 Table. List of bacterial strains, plasmids and phages used in the study.
(DOC)
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